Cstone Pharmaceuticals Forecast, price target & analysts
HK$4.94
3.89%
Hong Kong, Oct 30, 04:08 pm HKT.
Closed.
Why the stock moved Beta
ISIN
KYG2588M1006
Symbol
2616
Industry
Cstone Pharmaceuticals Target price 2026 - Analyst rating & recommendation
Powered by
Cstone Pharmaceuticals Classifications & Recommendation
Buy
89%
Hold
11%
Cstone Pharmaceuticals Price Target
| Target Price | HK$17.24 |
| Price | HK$4.94 |
| Potential | |
| Number of Estimates | 5 |
| 5 Analysts have issued a price target Cstone Pharmaceuticals 2027 . The average Cstone Pharmaceuticals target price is HK$17.24. This is higher than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 9 analysts: 8 Analysts recommend Cstone Pharmaceuticals to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Cstone Pharmaceuticals stock has an average upside potential 2027 of . Most analysts recommend the Cstone Pharmaceuticals stock at Purchase. |
Sales and Margin forecast 2026, 2027 & 2028
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million HK$ | ??? | ??? |
| ??? | ??? | |
| EBITDA Margin | ??? | ??? |
| ??? | ??? |
5 Analysts have issued a sales forecast Cstone Pharmaceuticals 2026 . The average Cstone Pharmaceuticals sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | ??? | ??? |
| ??? | ??? | |
| P/E | ??? | |
| EV/Sales | ??? |
5 Analysts have issued a Cstone Pharmaceuticals forecast for earnings per share. The average Cstone Pharmaceuticals EPS is
. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
Cstone Pharmaceuticals...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
